Free Trial

Stonegate Investment Group LLC Purchases 10,296 Shares of Danaher Co. (NYSE:DHR)

Danaher logo with Multi-Sector Conglomerates background

Stonegate Investment Group LLC lifted its position in Danaher Co. (NYSE:DHR - Free Report) by 4.9% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 220,369 shares of the conglomerate's stock after acquiring an additional 10,296 shares during the period. Danaher makes up approximately 1.6% of Stonegate Investment Group LLC's holdings, making the stock its 25th biggest holding. Stonegate Investment Group LLC's holdings in Danaher were worth $61,267,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also bought and sold shares of the company. Vanguard Group Inc. raised its position in shares of Danaher by 7.4% during the first quarter. Vanguard Group Inc. now owns 60,107,030 shares of the conglomerate's stock worth $15,009,928,000 after purchasing an additional 4,163,657 shares during the period. Legal & General Group Plc raised its holdings in Danaher by 2.4% during the 2nd quarter. Legal & General Group Plc now owns 5,964,031 shares of the conglomerate's stock worth $1,490,112,000 after buying an additional 139,989 shares during the period. Capital Research Global Investors lifted its stake in Danaher by 1.0% in the first quarter. Capital Research Global Investors now owns 5,125,470 shares of the conglomerate's stock valued at $1,279,932,000 after buying an additional 52,679 shares in the last quarter. Dimensional Fund Advisors LP boosted its holdings in shares of Danaher by 2.6% in the second quarter. Dimensional Fund Advisors LP now owns 3,398,649 shares of the conglomerate's stock valued at $849,195,000 after buying an additional 85,081 shares during the period. Finally, Massachusetts Financial Services Co. MA increased its position in shares of Danaher by 22.7% during the second quarter. Massachusetts Financial Services Co. MA now owns 3,047,728 shares of the conglomerate's stock worth $761,475,000 after acquiring an additional 563,546 shares in the last quarter. Institutional investors own 79.05% of the company's stock.

Insider Activity at Danaher

In related news, CFO Matthew Mcgrew sold 16,172 shares of the company's stock in a transaction that occurred on Thursday, August 1st. The shares were sold at an average price of $279.84, for a total transaction of $4,525,572.48. Following the completion of the transaction, the chief financial officer now directly owns 29,407 shares in the company, valued at $8,229,254.88. This represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. In other Danaher news, CFO Matthew Mcgrew sold 16,172 shares of the company's stock in a transaction dated Thursday, August 1st. The stock was sold at an average price of $279.84, for a total value of $4,525,572.48. Following the completion of the transaction, the chief financial officer now owns 29,407 shares of the company's stock, valued at $8,229,254.88. This represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, CEO Rainer Blair sold 9,007 shares of the stock in a transaction dated Wednesday, July 31st. The shares were sold at an average price of $280.00, for a total value of $2,521,960.00. Following the completion of the transaction, the chief executive officer now owns 97,983 shares of the company's stock, valued at $27,435,240. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 39,659 shares of company stock valued at $11,042,433 over the last ninety days. 11.10% of the stock is owned by corporate insiders.

Wall Street Analyst Weigh In

A number of brokerages recently weighed in on DHR. Stifel Nicolaus upped their target price on shares of Danaher from $235.00 to $250.00 and gave the stock a "hold" rating in a research note on Wednesday, July 24th. Royal Bank of Canada reaffirmed an "outperform" rating and set a $300.00 price target on shares of Danaher in a research report on Friday, September 6th. Bank of America lifted their price target on shares of Danaher from $270.00 to $275.00 and gave the company a "neutral" rating in a research note on Wednesday, July 24th. Wells Fargo & Company initiated coverage on Danaher in a research report on Tuesday, August 27th. They issued an "equal weight" rating and a $280.00 target price on the stock. Finally, Leerink Partners raised their price target on Danaher from $275.00 to $280.00 and gave the company an "outperform" rating in a research note on Wednesday, July 24th. Seven analysts have rated the stock with a hold rating and twelve have given a buy rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and an average target price of $282.12.

View Our Latest Report on Danaher

Danaher Price Performance

DHR traded up $2.35 on Friday, hitting $274.33. 1,949,811 shares of the stock were exchanged, compared to its average volume of 2,717,951. The firm has a market capitalization of $203.19 billion, a price-to-earnings ratio of 46.50, a PEG ratio of 4.49 and a beta of 0.83. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.43 and a quick ratio of 1.04. Danaher Co. has a 12 month low of $182.09 and a 12 month high of $281.70. The business has a 50-day moving average of $270.72 and a two-hundred day moving average of $259.92.

Danaher (NYSE:DHR - Get Free Report) last issued its quarterly earnings results on Tuesday, July 23rd. The conglomerate reported $1.72 earnings per share for the quarter, topping analysts' consensus estimates of $1.57 by $0.15. Danaher had a net margin of 16.94% and a return on equity of 11.06%. The company had revenue of $5.74 billion during the quarter, compared to the consensus estimate of $5.59 billion. During the same quarter in the prior year, the firm posted $2.05 EPS. The firm's quarterly revenue was down 2.9% on a year-over-year basis. Sell-side analysts forecast that Danaher Co. will post 7.59 EPS for the current fiscal year.

Danaher Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, October 25th. Investors of record on Friday, September 27th will be given a dividend of $0.27 per share. The ex-dividend date is Friday, September 27th. This represents a $1.08 annualized dividend and a dividend yield of 0.39%. Danaher's dividend payout ratio is currently 18.31%.

About Danaher

(Free Report)

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.

Further Reading

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Should you invest $1,000 in Danaher right now?

Before you consider Danaher, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Danaher wasn't on the list.

While Danaher currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 10 Best AI Stocks to Own in 2024 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Billionaires Bet Big on Cavco and Champion Homes
3 Momentum Stock Picks With Room to Run
Champion Homes’ 37% Sales Surge: Time to Invest?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines